The irritable bowel drug Zelnorm has been been suspended due to links with such heart related ailments as angina, heart attacks, and strokes. Zelnorm, manufactured by Novartis, is the second drug in two days to come off the market for links to heart problems.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.